Non-selective beta-blockers attenuate cytokine-driven CD8 + T cell activation in decompensated liver cirrhosis

Background Decompensated cirrhosis is driven by systemic inflammation, a hallmark of cirrhosis-associated immune dysfunction. Non-selective beta-blockers (NSBBs) improve survival and reduce inflammation yet immunological mechanisms remain unclear. Objective We investigated whether NSBBs directly modulate cytokine-driven CD8+ T cell activation implicated in inflammatory pathology in advanced cirrhosis. Design CD8+ T cells from paired blood and ascites of patients with decompensated cirrhosis were analysed ex vivo and following stimulation with propranolol by multiparameter flow cytometry. Antigen-specific responses were assessed using cytomegalovirus (CMV) pp65 stimulation. Bulk RNA sequencing defined transcriptional effects of beta-adrenergic blockade in CD8+ T cells. Single-cell RNA sequencing datasets were reanalysed to characterise beta-adrenergic receptor expression across CD8+ T cell subsets. Clinical associations were explored in an independent retrospective cirrhosis cohort. Results CD8+ T cells predominantly expressed beta-2 adrenergic receptor (ADRB2), with enrichment in effector-memory subsets. Propranolol selectively attenuated cytokine-driven CD8+ T cell activation, reducing CD69+CXCR6+ and NKG2D+ phenotypes and interferon-gamma (IFNγ)/tumour necrosis factor-alpha (TNFα) production, with limited effects on T-cell receptor-mediated and CMV pp65-induced responses. Transcriptomic profiling revealed suppression of IFN-associated inflammatory programmes associated with signal transducer and activator of transcription 1 (STAT1)/IFN regulatory factor 1 (IRF1) downregulation. Ex vivo, NSBB-treated patients exhibited lower frequencies of cytokine-activated CD8+ T cells, particularly in blood, consistent with higher circulating NSBB levels. In the retrospective cohort, NSBB therapy remained associated with lower alanine aminotransferase (ALT) levels and white blood cell (WBC) counts after adjustment for clinical confounders. Conclusion Beta-adrenergic blockade dampens cytokine-driven CD8+ T cell activation, while CMV-specific responses remain largely preserved. These findings suggest a cellular mechanism underlying the anti-inflammatory effects of NSBBs and implicate a potential neuroimmune pathway that may contribute to improved outcomes in decompensated cirrhosis.

Authors

Institutions

Publication Details

Journal
Gut
Published
2026-11-17
DOI
https://doi.org/10.1136/gutjnl-2026-338727
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Non-selective beta-blockers attenuate cytokine-driven CD8 + T cell activation in decompensated liver cirrhosis

Roni Souleiman, Markus Cornberg, Eui‐Cheol Shin, Ines Tapken et al.
2 links
Gut
Liver Disease and Transplantation
article

Non-selective beta-blockers attenuate cytokine-driven CD8 + T cell activation in decompensated liver cirrhosis

Roni Souleiman, Markus Cornberg, Eui‐Cheol Shin, Ines Tapken, Benjamin Maasoumy, Christian Niehaus, Gabriela Zurek, Sebastian Klein, Erich Freyer, Heiner H. Wedemeyer, Anke R.M. Kraft, Soyoung Kim, Ayesha Lietzau, Kareem Haal, Tammo L Tergast, Hannes Kolde, Isabell Niehaus, Sarah L Schütte
article en

Abstract

Background Decompensated cirrhosis is driven by systemic inflammation, a hallmark of cirrhosis-associated immune dysfunction. Non-selective beta-blockers (NSBBs) improve survival and reduce inflammation yet immunological mechanisms remain unclear. Objective We investigated whether NSBBs directly modulate cytokine-driven CD8+ T cell activation implicated in inflammatory pathology in advanced cirrhosis. Design CD8+ T cells from paired blood and ascites of patients with decompensated cirrhosis were analysed ex vivo and following stimulation with propranolol by multiparameter flow cytometry. Antigen-specific responses were assessed using cytomegalovirus (CMV) pp65 stimulation. Bulk RNA sequencing defined transcriptional effects of beta-adrenergic blockade in CD8+ T cells. Single-cell RNA sequencing datasets were reanalysed to characterise beta-adrenergic receptor expression across CD8+ T cell subsets. Clinical associations were explored in an independent retrospective cirrhosis cohort. Results CD8+ T cells predominantly expressed beta-2 adrenergic receptor (ADRB2), with enrichment in effector-memory subsets. Propranolol selectively attenuated cytokine-driven CD8+ T cell activation, reducing CD69+CXCR6+ and NKG2D+ phenotypes and interferon-gamma (IFNγ)/tumour necrosis factor-alpha (TNFα) production, with limited effects on T-cell receptor-mediated and CMV pp65-induced responses. Transcriptomic profiling revealed suppression of IFN-associated inflammatory programmes associated with signal transducer and activator of transcription 1 (STAT1)/IFN regulatory factor 1 (IRF1) downregulation. Ex vivo, NSBB-treated patients exhibited lower frequencies of cytokine-activated CD8+ T cells, particularly in blood, consistent with higher circulating NSBB levels. In the retrospective cohort, NSBB therapy remained associated with lower alanine aminotransferase (ALT) levels and white blood cell (WBC) counts after adjustment for clinical confounders. Conclusion Beta-adrenergic blockade dampens cytokine-driven CD8+ T cell activation, while CMV-specific responses remain largely preserved. These findings suggest a cellular mechanism underlying the anti-inflammatory effects of NSBBs and implicate a potential neuroimmune pathway that may contribute to improved outcomes in decompensated cirrhosis.

Gut
Leibniz University Hannover (DE), Karolinska University Hospital (SE), Korea Advanced Institute of Science and Technology (KR), University of Veterinary Medicine Hannover, Foundation (DE), Karolinska Institutet (SE), Medizinische Hochschule Hannover (DE), German Center for Infection Research (DE), Helmholtz Centre for Infection Research (DE), German Liver Foundation (DE), Centre for Individualised Infection Medicine (DE), Center for Experimental and Clinical Infection Research (DE), CAIMed - Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin (DE)
Deutsches Zentrum für Infektionsforschung, Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Medizinischen Hochschule Hannover
Good health and well-being
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon